A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Primary objective * The tolerability and safety of SAR443809 Secondary * The PK parameters of SAR443809 * The PD activity of SAR443809 * The immunogenicity of SAR443809
Epistemonikos ID: dcfbc3e90b2bb2e519898238b4863cc8a366dfd6
First added on: May 15, 2024